High blood pressure, or hypertension, is a widespread health concern affecting over one billion people globally [2]. It stands as the leading preventable risk factor for cardiovascular disease (CVD), contributing to millions of deaths each year [2, 8]. Uncontrolled hypertension can initiate a cascade of health problems, leading to structural and functional damage to the cardiovascular system, atherosclerosis, and ultimately increasing the risk of events like heart attack and stroke [2].
Despite its significant impact, less than half of those with hypertension are diagnosed and receiving adequate treatment [2, 8]. Suboptimal management of elevated blood pressure remains a challenge worldwide, particularly in low- and middle-income countries [2, 8]. The overarching goal of hypertension management is to reduce the morbidity and mortality associated with cardiovascular diseases [8].
General Blood Pressure Targets
Guidelines for blood pressure management have evolved to provide clearer targets for patients. For many individuals with hypertension, especially those who have experienced a stroke, a blood pressure target of less than 130/80 mm Hg is recommended [4]. This target aligns with the 2017 American College of Cardiology and American Heart Association (ACC/AHA) guidelines, which redefined hypertension as a blood pressure of 130/80 mm Hg or greater and set a treatment goal of less than 130/80 mm Hg [7].
Overall, randomized trials across various age groups consistently demonstrate that lowering blood pressure can reduce the incidence of cardiovascular disease and mortality [5]. These general targets provide a framework, but treatment strategies are often individualized based on a patient's specific health profile and conditions.
Tailoring Treatment for Specific Situations
Managing blood pressure can become more complex in certain patient populations, requiring a nuanced approach:
-
Acute Stroke: Hypertension is frequently observed in patients presenting with a stroke and is independently linked to poorer outcomes [1]. However, intensive blood pressure reduction immediately after receiving alteplase (a clot-busting medication) has not been shown to improve outcomes [1]. For patients with large vessel blockages, lower blood pressure targets after intervention might be beneficial [1]. In cases of intracerebral hemorrhage, intensive blood pressure reduction may disproportionately benefit or harm specific patient subgroups [1]. For subarachnoid hemorrhage, robust data guiding blood pressure management is limited, and expert consensus often guides decision-making [1].
-
Frailty in Older Adults: Treating hypertension in older patients who are frail presents unique challenges [3]. Current guidelines suggest screening for frailty among older hypertensive patients and offer new recommendations for blood pressure-lowering treatment in this population [3]. Clinicians may consider relaxing treatment targets for some frail individuals, for example, if their systolic blood pressure is above 150 mm Hg [5]. When treatment is intensified, it might involve selecting specific medications or using combination therapy [5]. Further research is needed to optimize hypertension management in this vulnerable group [5].
Comprehensive Approaches to Management
Effective hypertension management involves a combination of strategies, often tailored to the individual:
-
Pharmacological Treatments: A variety of antihypertensive medications are available [2, 6]. While the benefits of blood pressure-lowering drugs for stroke prevention are well-established, ongoing research aims to determine the most effective and safest single or combined therapies [6]. Systematic reviews are being conducted to compare different pharmacological interventions for stroke prevention [6].
-
Non-Pharmacological Approaches: These strategies are an integral part of managing hypertension and reducing cardiovascular risk [2]. While specific details are not provided in the sources, they are recognized as part of a comprehensive treatment plan [2].
-
Health Systems Strengthening: To improve hypertension control, particularly in low- and middle-income countries, a health systems-strengthening approach is advocated [8]. This includes implementing standardized treatment protocols, ensuring access to a core set of affordable medications, establishing registries for patient monitoring, empowering patients, and fostering team-based care [8].
Challenges and Future Directions in Hypertension Care
Despite the known impact of hypertension on health outcomes, many prospective trials assessing the effectiveness of blood pressure reduction have yielded neutral or inconclusive results [1]. This highlights the complexity of hypertension management and the need for ongoing research.
The field is continuously exploring new paradigms and emerging approaches for managing hypertension and reducing cardiovascular disease risk [2]. There is also a recognized need for better-designed clinical trials, especially those that can inform the care of specific populations, such as older people with frailty [5]. By addressing these challenges, healthcare providers aim to improve blood pressure control and reduce the global burden of cardiovascular disease [8].
Sources
[1] Blood Pressure in Acute Stroke and Secondary Stroke Prevention. (Current neurology and neuroscience reports, 2022) https://pubmed.ncbi.nlm.nih.gov/35332513/
[2] Benefits Beyond Hypertension Control: Current and Evolving Treatment Strategies for Prevention of Cardiovascular Diseases. (Current hypertension reviews, 2026) https://pubmed.ncbi.nlm.nih.gov/42311016/
[3] Hypertension Treatment in Frail Older Adults: A Systematic Review and Appraisal of Guidelines. (Drugs & aging, 2023) https://pubmed.ncbi.nlm.nih.gov/37594718/
[4] 2021 Taiwan Stroke Society Guidelines of blood pressure control for ischemic stroke prevention. (Journal of the Chinese Medical Association : JCMA, 2022) https://pubmed.ncbi.nlm.nih.gov/35507097/
[5] How to design a hypertension treatment trial that informs care of older people with frailty: a survey of clinicians in Ireland and the UK. (Age and ageing, 2021) https://pubmed.ncbi.nlm.nih.gov/33063103/
[6] Blood pressure lowering and stroke prevention: a systematic review and network meta-analysis protocol. (Annals of translational medicine, 2019) https://pubmed.ncbi.nlm.nih.gov/31700925/
[7] Prevalence of Hypertension, Treatment, and Blood Pressure Targets in Canada Associated With the 2017 American College of Cardiology and American Heart Association Blood Pressure Guidelines. (JAMA network open, 2019) https://pubmed.ncbi.nlm.nih.gov/30848811/
[8] Improved Blood Pressure Control to Reduce Cardiovascular Disease Morbidity and Mortality: The Standardized Hypertension Treatment and Prevention Project. (Journal of clinical hypertension (Greenwich, Conn.), 2016) https://pubmed.ncbi.nlm.nih.gov/27378199/